Dong-E-E-Jiao Co.,Ltd.

Shenzhen Stock Exchange 000423.SZ

Dong-E-E-Jiao Co.,Ltd. Revenue for the year ending December 31, 2023: USD 664.15 M

Dong-E-E-Jiao Co.,Ltd. Revenue is USD 664.15 M for the year ending December 31, 2023, a 13.39% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Dong-E-E-Jiao Co.,Ltd. Revenue for the year ending December 31, 2022 was USD 585.70 M, a -3.31% change year over year.
Dong-E-E-Jiao Co.,Ltd. Revenue for the year ending December 31, 2021 was USD 605.75 M, a 15.97% change year over year.
Dong-E-E-Jiao Co.,Ltd. Revenue for the year ending December 31, 2020 was USD 522.33 M, a 22.94% change year over year.
Dong-E-E-Jiao Co.,Ltd. Revenue for the year ending December 31, 2019 was USD 424.86 M, a -60.18% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 000423.SZ

Dong-E-E-Jiao Co.,Ltd.

CEO	Mr. Jie Cheng
IPO Date	July 29, 1996
Location	China
Headquarters	78 Ejiao Street
Employees	3,678
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.

Key trends

Past 5 years